Literature DB >> 16899964

Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice.

Christina M van der Feltz-Cornelis1, Patricia van Oppen, Herman J Adèr, Richard van Dyck.   

Abstract

BACKGROUND: Patients with persistent medically unexplained symptoms often exhibit general dysfunction and psychiatric comorbidity and frequently resist psychiatric referral. The aim of this study was to evaluate the efficacy of a collaborative care model including training for general practitioners (GPs) and a psychiatric consultation model for patients with persistent medically unexplained symptoms in general practice.
METHOD: Randomised controlled trial. Cluster randomisation at GP practices and multilevel analysis were performed. A total of 81 patients from 36 general practices completed the study. A collaborative care model of training and psychiatric consultation in general practice in the presence of the GP was compared with training plus care as usual by the GP. Outcome assessment on the patients' well-being, functioning and utilisation of health care services was performed 6 weeks and 6 months later.
RESULTS: All the patients had somatoform disorders (Whitely Index 7.46), and 86% had comorbid psychiatric disorders. In the intervention group, the severity of the main medically unexplained symptoms decreased by 58%. The patients' social functioning improved. The utilization of health care was lower than in the care as usual group.
CONCLUSIONS: A collaborative care model combining training with psychiatric consultation in the general practice setting is an effective intervention in the treatment of persistent medically unexplained symptoms. Anxiety and depressive disorders are highly comorbid in this group. The findings warrant a larger study.

Entities:  

Mesh:

Year:  2006        PMID: 16899964     DOI: 10.1159/000093949

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  34 in total

1.  The cost of somatisation among the working-age population in England for the year 2008-2009.

Authors:  Sarah L Bermingham; Alan Cohen; John Hague; Michael Parsonage
Journal:  Ment Health Fam Med       Date:  2010-06

2.  [Somatoform disorders. Clinical evidence, etiology, pathogenesis, and therapy].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 3.  Developmental influences on medically unexplained symptoms.

Authors:  C A Tony Buffington
Journal:  Psychother Psychosom       Date:  2009-03-09       Impact factor: 17.659

4.  Validation of the 4DSQ somatization subscale in the occupational health care setting as a screener.

Authors:  Lars de Vroege; Wilco H M Emons; Klaas Sijtsma; Rob Hoedeman; Christina M van der Feltz-Cornelis
Journal:  J Occup Rehabil       Date:  2015-03

5.  [Patient satisfaction with the patient-doctor relationship measured using the questionnaire (PDRQ-9)].

Authors:  Jesús Martín-Fernández; M Isabel del Cura-González; Tomás Gómez-Gascón; Eva Fernández-López; Guadalupe Pajares-Carabajal; Bernardo Moreno-Jiménez
Journal:  Aten Primaria       Date:  2010-02-08       Impact factor: 1.137

6.  Non-specific, functional, and somatoform bodily complaints.

Authors:  Rainer Schaefert; Constanze Hausteiner-Wiehle; Winfried Häuser; Joram Ronel; Markus Herrmann; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594

7.  The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge.

Authors:  Rob Hoedeman; Annette H Blankenstein; Boudien Krol; Petra C Koopmans; Johan W Groothoff
Journal:  J Occup Rehabil       Date:  2010-06

8.  Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial.

Authors:  Christina M van der Feltz-Cornelis; Rob Hoedeman; Fransina J de Jong; Jolanda Ac Meeuwissen; Hanneke W Drewes; Niels C van der Laan; Herman J Adèr
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 9.  Advances in understanding illness anxiety.

Authors:  Kelli J Harding; Natalia Skritskaya; Emily Doherty; Brian A Fallon
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

10.  Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment.

Authors:  Rob Hoedeman; Boudien Krol; Nettie Blankenstein; Petra C Koopmans; Johan W Groothoff
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.